Technical Analysis for EDAP - EDAP TMS S.A.

Grade Last Price % Change Price Change
grade D 2.7 3.45% 0.09
EDAP closed up 3.45 percent on Friday, June 5, 2020, on approximately normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up
Historical EDAP trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Spinning Top Other 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Outside Day Range Expansion 3.45%
Wide Bands Range Expansion 3.45%
NR7 Range Contraction 3.85%
Wide Bands Range Expansion 3.85%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 6.09%
Doji - Bullish? Reversal 6.09%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


EDAP TMS S.A., through its subsidiaries, engages in the development, production, marketing, distribution, and maintenance of minimally invasive medical devices for the treatment of urological diseases. The company operates in two divisions, High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division offers medical devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. This division provides Ablatherm, a HIFU-based ultrasound guided device for the treatment of organ-confined prostate cancer. Its HIFU technology allows the surgeon to destroy a defined area of diseased tissue without damaging surrounding tissue and organs. This division also engages in the leasing of equipment, as well as the sale of disposables, spare parts, and maintenance services. It markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. The UDS division provides medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. This division manufactures lithotripters, including the Sonolith i-move and the Sonolith i-sys, for the treatment of urinary tract stones by means of ESWL technology. It is also involved in the leasing of lithotripters, as well as the sale of disposables, spare parts, and maintenance services. This division markets and sells its products through its direct sales and service platform, as well as through agents and third-party distributors. The company's customers include public and private hospitals, urology clinics, and research institutions worldwide. EDAP TMS S.A. was founded in 1979 and is based in Vaulx-en-Velin, France.
Medicine Health Medical Specialties Maintenance Services Prostate Cancer Ultrasound Magnetic Resonance Imaging Urology Medical Ultrasonography High Intensity Focused Ultrasound Localized Tumors

Is EDAP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 5.39
52 Week Low 1.46
Average Volume 94,886
200-Day Moving Average 3.66
50-Day Moving Average 2.29
20-Day Moving Average 2.41
10-Day Moving Average 2.63
Average True Range 0.19
ADX 29.36
+DI 26.86
-DI 11.31
Chandelier Exit (Long, 3 ATRs ) 2.25
Chandelier Exit (Short, 3 ATRs ) 2.56
Upper Bollinger Band 2.87
Lower Bollinger Band 1.94
Percent B (%b) 0.81
BandWidth 38.75
MACD Line 0.11
MACD Signal Line 0.08
MACD Histogram 0.0282
Fundamentals Value
Market Cap 78.29 Million
Num Shares 29 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 2.00
Price-to-Book 2.88
PEG Ratio 86.70
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.09
Resistance 3 (R3) 3.09 2.94 3.03
Resistance 2 (R2) 2.94 2.84 2.95 3.01
Resistance 1 (R1) 2.82 2.78 2.88 2.83 2.99
Pivot Point 2.68 2.68 2.71 2.69 2.68
Support 1 (S1) 2.56 2.58 2.62 2.57 2.41
Support 2 (S2) 2.42 2.52 2.42 2.39
Support 3 (S3) 2.30 2.42 2.37
Support 4 (S4) 2.31